Decreased erythrocyte insulin binding in hypertensive subjects with hyperinsulinemia

American Journal of Hypertension

Volumn 15, Issue 4 I, 2002, Pages 296-301

  Corry, Dalila B ^b,c   Joolhar, Fowrooz S ^b   Hori, Mark T ^a,c   Tuck, Michael L ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Erythrocytes; Essential hypertension; Glucose; Insulin; Insulin receptor; Insulin resistance; Protein tyrosine kinase

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPERTENSION; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY;

ADULT; ERYTHROCYTES; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; RECEPTOR, INSULIN;

EID: 0036117383     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02336-6     Document Type: Article

References (32)

1. Serum-insulin in essential hypertension and peripheral vascular disease
2. Insulin resistance in essential hypertension
3. Role of insulin resistance in human disease
4. Insulin resistance is a characteristic feature of primary hypertension independent of obesity
5. Hypertension and associated metabolic abnormalities-the role of insulin resistance and sympathoadrenal system
6. Overview of the association between insulin and atherosclerosis
7. Insulin resistance and cardiovascular disease
8. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells
9. Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects
10. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man
11. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in humans
12. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man
13. Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: Role of insulin
14. Effects of insulin on kidney function and sodium excretion in healthy subjects
15. Impaired fibrinolysis and insulin resistance in patients with hypertension
16. Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II diabetes
17. Partial purification and characterization of cytosolic tyrosine protein kinase(s) from human erythrocytes
18. An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome
19. Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man
20. Insulin radioreceptor assay for human erythrocytes
21. Characteristics of human erythrocyte insulin receptors
22. The attraction of proteins for small molecules and ions
23. Ligand: A versatile computerized approach for characterization of binding systems
24. Enzyme-linked immunosorbant assay method for human autophosphorylated insulin receptor
25. Hyperinsulinemia in hypertension: Increased secretion, reduced clearance or both?
26. Impaired insulin action on skeletal muscle metabolism in essential hypertension
27. Red blood cell insulin receptors in health and disease
28. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor
29. Diminished insulin receptors on erythrocyte ghosts in nonobese patients with essential hypertension independent of hyperinsulinemia
30. Bisoprolol and captopril effects on insulin receptor tyrosine kinase activity in essential hypertension
31. Insulin receptor number in arterial hypertension: Response to treatment with fosinopril or atenolol
32. Cellular ions in hypertension, diabetes and obesity